LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 38 filers reported holding LUMOS PHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $8,310 | +9.5% | 3,582 | +33.1% | 0.00% | – |
| Q1 2024 | $7,589 | +51.6% | 2,691 | +71.0% | 0.00% | – |
| Q4 2023 | $5,005 | -21.5% | 1,574 | -18.5% | 0.00% | – |
| Q3 2023 | $6,376 | +28.5% | 1,932 | +28.5% | 0.00% | – |
| Q2 2023 | $4,960 | +44990.9% | 1,503 | -53.2% | 0.00% | – |
| Q1 2023 | $11 | +10.0% | 3,211 | +14.8% | 0.00% | – |
| Q4 2022 | $10 | -100.0% | 2,797 | +8.3% | 0.00% | – |
| Q3 2022 | $23,000 | -11.5% | 2,582 | -21.3% | 0.00% | -100.0% |
| Q2 2022 | $26,000 | +2500.0% | 3,280 | +5025.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 64 | -25.6% | 0.00% | – |
| Q4 2021 | $1,000 | – | 86 | +8500.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 1 | -99.2% | 0.00% | – |
| Q2 2021 | $1,000 | -66.7% | 123 | -48.3% | 0.00% | – |
| Q1 2021 | $3,000 | -66.7% | 238 | -77.2% | 0.00% | -100.0% |
| Q1 2020 | $9,000 | – | 1,043 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 407,192 | $14,540,000 | 2.80% |
| Opaleye Management Inc. | 281,287 | $10,045,000 | 1.31% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 936,291 | $33,435,000 | 0.66% |
| NEA Management Company, LLC | 526,663 | $18,807,000 | 0.50% |
| Investors Financial Group, LLC | 18,200 | $650,000 | 0.43% |
| One68 Global Capital, LLC | 5,855 | $209,000 | 0.42% |
| Wealth Advisors of Iowa, LLC | 11,760 | $420,000 | 0.26% |
| Blackstone Inc. | 468,145 | $16,717,000 | 0.06% |
| Foster Group, Inc. | 7,283 | $221,000 | 0.04% |
| Texas Yale Capital Corp. | 16,000 | $571,000 | 0.04% |